Microbot Medical (MBOT) Assets (2010 - 2026)

Microbot Medical's Assets history runs 17 years deep, the most recent figure standing at $78.1 million for Q1 2026.

• Quarterly Assets rose 152.71% year-over-year to $78.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.1 million (up 152.71% YoY) and the FY2025 annual result came in at $81.5 million, up 1252.08% from the prior year.
• Assets was $78.1 million for Q1 2026 at Microbot Medical, down from $81.5 million in the prior quarter.
• Across five years, Assets topped out at $81.8 million in Q3 2025 and bottomed at $5.2 million in Q3 2024.
• A 5-year average of $23.9 million and a median of $9.5 million in 2022 frame the typical range for Assets.
• Annual changes were most pronounced in 2022 — Assets sank 62.39% — and 2025, when it soared 1469.89%.
• Microbot Medical's Assets stood at $9.5 million in 2022, then dropped by 12.69% to $8.3 million in 2023, then decreased by 27.57% to $6.0 million in 2024, then jumped by 1252.08% to $81.5 million in 2025, then decreased by 4.27% to $78.1 million in 2026.
• Business Quant data shows MBOT's Assets at $78.1 million in Q1 2026, $81.5 million in Q4 2025, and $81.8 million in Q3 2025.